Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ataxin 2 | Starlite/ChEMBL | No references |
Homo sapiens | polymerase (DNA directed) iota | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | Protein orai-1 | 0.2214 | 1 | 1 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0017 | 0.5 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0023 | 0.0017 | 0.5 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0023 | 0.0017 | 0.5 |
Plasmodium vivax | ataxin-2 like protein, putative | 0.003 | 0.0049 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0049 | 1 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.003 | 0.0049 | 0.5 |
Brugia malayi | hypothetical protein | 0.003 | 0.0049 | 0.0049 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0023 | 0.0017 | 0.5 |
Giardia lamblia | DINP protein human, muc B family | 0.0023 | 0.0017 | 0.5 |
Echinococcus multilocularis | calcium release activated calcium channel | 0.2214 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.003 | 0.0049 | 0.0033 |
Schistosoma mansoni | Protein orai-1 | 0.2214 | 1 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0017 | 0.0017 |
Echinococcus granulosus | calcium release activated calcium channel | 0.2214 | 1 | 1 |
Leishmania major | hypothetical protein, conserved | 0.003 | 0.0049 | 1 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0023 | 0.0017 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0049 | 0.5 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.003 | 0.0049 | 0.5 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0023 | 0.0017 | 0.0017 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0023 | 0.0017 | 0.5 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.003 | 0.0049 | 1 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.003 | 0.0049 | 1 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0023 | 0.0017 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.2214 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.1042 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 3.9811 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Potency (functional) | 10 uM | PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 44.6684 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1). (Class of assay: confirmatory) [Related pubchem assays: 1030 (qHTS Validation Assay for Inhibitors of aldehyde dehydrogenase 1 (ALDH1A1))] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.